Afrezza makes its debut

Danbury based Mannkind is expected to ramps up the manufacturing of Afrezza, an inhalable form of insulin, that was launched this week and is now available at pharmacies throughout the United States. Photo: Contributed Photo This photo provided by Sanofi shows an Afrezza inhaler with cartridges of inhalation powder.



via Danbury Newswire http://ift.tt/1zYRBjF